The cyclins and their catalytic partners, the Cyclin Dependent Kinases (CDKs), are essential for progression through the cell cycle. Cyclin/kinase complexes containing cyclins A or E are active primarily in late G1 to S phase and both have been shown to phosphorylate histone H1 and the retinoblastoma gene product (pRb) in vitro. Despite these similarities, cyclins A and E display differences in CDK activation and substrate specificity. We find that ill vitro, cyclin E/CDK2 and cyclin A/CDK2 phosphorylate histone H1 similarly but only cyclin A/CDK2 phosphorylates lamin B. While both cyclin A and cyclin E bind CDK1 efficiently, only cyclin A activates CDK1 kinase activity. Using chimeric proteins between cyclins A and E we find that both the cyclin box and C-terminus of cyclins A and E are required for CDK binding, activation acid targeting of substrate specificity.
CITATION STYLE
Horton, L. E., & Templeton, D. J. (1997). The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene, 14(4), 491–498. https://doi.org/10.1038/sj.onc.1200851
Mendeley helps you to discover research relevant for your work.